- Investing Ideas
- /
- Materials Healthcare Sector
Materials Healthcare Sector
Results
2305
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2305 companies
Atossa Therapeutics
Market Cap: US$112.4m
Operates as a clinical-stage biopharmaceutical company that develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States.
ATOS
US$0.83
7D
-14.3%
1Y
-43.0%
Agape ATP
Market Cap: US$111.5m
An investment holding company, supplies health and wellness products and health solution advisory services in Malaysia.
ATPC
US$2.06
7D
0.5%
1Y
-63.0%
ALT5 Sigma
Market Cap: US$110.7m
Provides blockchain-powered technologies worldwide.
ALTS
US$8.91
7D
31.0%
1Y
179.3%
Sagimet Biosciences
Market Cap: US$109.8m
A clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic pathways in the United States.
SGMT
US$3.45
7D
7.1%
1Y
-28.4%
HLS Therapeutics
Market Cap: CA$147.1m
A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders, central nervous system, and cardiovascular disease in Canada, the United States, and internationally.
HLS
CA$4.68
7D
-2.5%
1Y
20.6%
Vaxart
Market Cap: US$107.1m
A clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform in the United States.
VXRT
US$0.46
7D
-8.2%
1Y
-46.5%
Kyverna Therapeutics
Market Cap: US$106.8m
Kyverna Therapeutics, Inc., clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases.
KYTX
US$2.27
7D
-2.2%
1Y
-82.5%
ACC Aviation Holdings
Market Cap: US$106.2m
Focuses on developing canna powder products.
CAVG
US$0.42
7D
-6.7%
1Y
-27.3%
Kewaunee Scientific
Market Cap: US$105.2m
Designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products.
KEQU
US$35.60
7D
-4.6%
1Y
-13.0%
Entasis Therapeutics Holdings
Market Cap: US$104.8m
Entasis Therapeutics Holdings Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibacterial products to treat serious infections caused by multidrug-resistant pathogens in the United States.
ETTX
US$2.19
7D
0%
1Y
-14.8%
Orchestra BioMed Holdings
Market Cap: US$104.6m
Operates as a biomedical company.
OBIO
US$2.72
7D
-6.2%
1Y
-48.7%
Agenus
Market Cap: US$103.9m
A clinical-stage biotechnology company, discovers and develops therapies to activate the body's immune system against cancer and infections in the United States and internationally.
AGEN
US$3.82
7D
9.8%
1Y
-72.0%
Assembly Biosciences
Market Cap: US$103.6m
A biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide.
ASMB
US$13.52
7D
0.7%
1Y
-10.3%
BioSig Technologies
Market Cap: US$103.1m
A medical technology company, provides digital signal processing technology platform services in the United States.
BSGM
US$5.28
7D
102.3%
1Y
205.2%
Achieve Life Sciences
Market Cap: US$103.0m
A clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction.
ACHV
US$3.04
7D
-1.3%
1Y
-43.8%
Cassava Sciences
Market Cap: US$102.4m
A clinical stage biotechnology company, develops drugs for neurodegenerative diseases.
SAVA
US$2.11
7D
1.0%
1Y
-90.3%
Lexeo Therapeutics
Market Cap: US$102.2m
A clinical stage genetic medicine company, focuses on hereditary and acquired diseases with high unmet need in the United States.
LXEO
US$2.82
7D
-13.0%
1Y
-81.8%
iCAD
Market Cap: US$102.0m
Provides AI-powered cancer detection solutions in the United States.
ICAD
US$3.73
7D
-6.5%
1Y
136.1%
MDxHealth
Market Cap: US$102.0m
A commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally.
MDXH
US$2.04
7D
-2.4%
1Y
-25.3%
Caribou Biosciences
Market Cap: US$101.8m
A clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and autoimmune diseases in the United States and internationally.
CRBU
US$1.02
7D
8.7%
1Y
-65.7%
Xtant Medical Holdings
Market Cap: US$101.2m
Provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally.
XTNT
US$0.74
7D
11.2%
1Y
-1.9%
Contineum Therapeutics
Market Cap: US$101.2m
A clinical stage biopharmaceutical company, engages in developing of small molecules different therapies for neuroscience, inflammation, and immunology indications with high unmet need in the United States.
CTNM
US$3.57
7D
1.6%
1Y
-77.4%
Cardiff Lexington
Market Cap: US$101.1m
Operates in the health care industry in the United States.
CDIX
US$6.50
7D
0%
1Y
-7.1%
Ironwood Pharmaceuticals
Market Cap: US$100.3m
A biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally.
IRWD
US$0.57
7D
-0.6%
1Y
-90.5%
Aroa Biosurgery
Market Cap: AU$155.2m
Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.
ARX
AU$0.45
7D
2.3%
1Y
-8.2%
MacroGenics
Market Cap: US$99.7m
A clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States.
MGNX
US$1.51
7D
-4.4%
1Y
-66.8%
Happy Belly Food Group
Market Cap: CA$135.9m
Provides food products in Canada.
HBFG
CA$1.05
7D
-0.9%
1Y
112.1%
Nautilus Biotechnology
Market Cap: US$98.9m
A development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome.
NAUT
US$0.73
7D
-11.2%
1Y
-72.8%
OncoCyte
Market Cap: US$98.4m
Operates as a precision diagnostics company in the United States and internationally.
OCX
US$3.37
7D
20.8%
1Y
19.1%
Cuprina Holdings (Cayman)
Market Cap: US$97.4m
A biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds.
CUPR
US$4.49
7D
0.2%
1Y
n/a
C4 Therapeutics
Market Cap: US$97.3m
A clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins.
CCCC
US$1.38
7D
0%
1Y
-74.8%
BioSyent
Market Cap: CA$132.2m
Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.
RX
CA$11.95
7D
1.7%
1Y
30.6%
TurnKey Capital
Market Cap: US$96.1m
HealthSpan Medical Systems, Inc. develops marijuana based intravenous therapy (IV) infusion blends for healthcare practitioners.
TKCI
US$0.23
7D
-71.6%
1Y
n/a
Coya Therapeutics
Market Cap: US$95.5m
A clinical-stage biotechnology company, develops proprietary therapies to enhance the function of regulatory T cells (Tregs).
COYA
US$5.90
7D
-0.5%
1Y
-25.4%
Cibus
Market Cap: US$95.2m
An agricultural biotechnology company, develops and licenses gene edited plant traits using gene editing technologies to enhance farming productivity or produce renewable low carbon plant products.
CBUS
US$2.53
7D
-10.3%
1Y
-83.7%
EMVision Medical Devices
Market Cap: AU$146.2m
Engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia.
EMV
AU$1.71
7D
-3.4%
1Y
-10.5%